Capstone Triton Financial Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,683
| Closed | -$319K | – | 111 |
|
|
2024
Q2 | $319K | Sell |
2,683
-588
| -18% | -$69.8K | 0.22% | 84 |
|
|
2024
Q1 | $349K | Sell |
3,271
-261
| -7% | -$27.8K | 0.25% | 84 |
|
|
2023
Q4 | $351K | Sell |
3,532
-2,081
| -37% | -$207K | 0.26% | 82 |
|
|
2023
Q3 | $580K | Sell |
5,613
-44
| -0.8% | -$4.55K | 0.42% | 66 |
|
|
2023
Q2 | $687K | Sell |
5,657
-110
| -2% | -$13.4K | 0.47% | 66 |
|
|
2023
Q1 | $886K | Sell |
5,767
-638
| -10% | -$98K | 0.67% | 59 |
|
|
2022
Q4 | $1.15M | Sell |
6,405
-395
| -6% | -$71K | 0.92% | 38 |
|
|
2022
Q3 | $804K | Sell |
6,800
-922
| -12% | -$109K | 0.69% | 48 |
|
|
2022
Q2 | $1.3M | Sell |
7,722
-150
| -2% | -$25.3K | 0.99% | 35 |
|
|
2022
Q1 | $1.12M | Buy |
+7,872
| New | +$1.12M | 0.78% | 39 |
|
|
2021
Q4 | – | Sell |
-7,511
| Closed | -$2.63M | – | 111 |
|
|
2021
Q3 | $2.63M | Buy |
7,511
+286
| +4% | +$100K | 1.58% | 16 |
|
|
2021
Q2 | $1.7M | Buy |
7,225
+900
| +14% | +$212K | 1.04% | 30 |
|
|
2021
Q1 | $828K | Buy |
6,325
+3,641
| +136% | +$477K | 0.55% | 45 |
|
|
2020
Q4 | $280K | Buy |
+2,684
| New | +$280K | 0.17% | 87 |
|